Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence
Authors
Keywords
-
Journal
TUMORI
Volume -, Issue -, Pages 030089161983928
Publisher
SAGE Publications
Online
2019-03-25
DOI
10.1177/0300891619839282
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
- (2017) Thomas J. Johnston et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Androgen-deprivation therapy alone versus combined with radiation therapy or chemotherapy for nonlocalized prostate cancer: a systematic review and meta-analysis
- (2016) Qiang Wei et al. ASIAN JOURNAL OF ANDROLOGY
- Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences
- (2016) P. Ost et al. CLINICAL ONCOLOGY
- Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
- (2016) Jonathan L. Muldermans et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
- (2016) Darren M. C. Poon et al. BMC Urology
- Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France
- (2015) Nadine Houédé et al. BMC CANCER
- Castration-Resistant Prostate Cancer: AUA Guideline Amendment
- (2015) Michael S. Cookson et al. JOURNAL OF UROLOGY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer
- (2014) B. Detti et al. WORLD JOURNAL OF UROLOGY
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
- (2013) Emily F. Stamell et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Patient Demographics, Quality of Life, and Disease Features of Men With Newly Diagnosed Prostate Cancer: Trends in the PSA Era
- (2013) Allison S. Glass et al. UROLOGY
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- 682 EXPLORATORY ANALYSIS OF THE SAFETY PROFILE OF ABIRATERONE ACETATE (AA) IN PATIENTS (PTS) RECEIVING CONCOMITANT RADIATION THERAPY IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
- (2012) Fred Saad et al. JOURNAL OF UROLOGY
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiation-induced effects and the immune system in cancer
- (2012) Punit Kaur et al. Frontiers in Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now